Misbah Tahir
CIK 1787359 · Chief Financial Officer · last filed 2026-03-03
Misbah Tahir is a Chief Financial Officer who has filed 30 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for MAZE, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$328.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
30
-$328.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MAZE | Chief Financial Officer | — | $24.05 | — | $0 | 2 | 2026-03-03 |
| IGM Biosciences, Inc. (IGMS) Delisted | CHIEF FINANCIAL OFFICER | 170,061 | $1.27 | $216.0K | -$328.2K | 28 | 2025-07-25 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | MAZE | Grant (A) | — | $0 | EDGAR |
| 2025-09-02 | MAZE | Grant (A) | — | $0 | EDGAR |
| 2025-07-25 | IGM Biosciences, Inc. (IGMS) Delisted | Sell (S) | −8,741 | -$11.1K | EDGAR |
| 2025-06-20 | IGM Biosciences, Inc. (IGMS) Delisted | Sell (S) | −1,522 | -$1.8K | EDGAR |
| 2025-03-18 | IGM Biosciences, Inc. (IGMS) Delisted | Sell (S) | −7,329 | -$9.0K | EDGAR |
| 2024-12-18 | IGM Biosciences, Inc. (IGMS) Delisted | Sell (S) | −1,708 | -$12.8K | EDGAR |
| 2024-11-20 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +66,667 | $0 | EDGAR |
| 2024-09-17 | IGM Biosciences, Inc. (IGMS) Delisted | Sell (S) | −1,487 | -$17.2K | EDGAR |
| 2024-07-23 | IGM Biosciences, Inc. (IGMS) Delisted | Mixed | +35,333 | $0 | EDGAR |
| 2024-06-18 | IGM Biosciences, Inc. (IGMS) Delisted | Sell (S) | −1,570 | -$11.9K | EDGAR |